Publication | Closed Access

Calcium phosphate-polymer hybrid nanoparticles for enhanced triple negative breast cancer treatment via co-delivery of paclitaxel and miR-221/222 inhibitors

NanoparticlesNanomedicineEngineeringTherapeutic NanomaterialsMir-221/222 InhibitorsMedicinePolymer-drug ConjugateBreast CancerNano-drug DeliveryTumor TargetingBiomedical EngineeringOncologyRadiation Oncology